Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
9,228,073
-
Share change
-
+414,917
-
Total reported value
-
$170,623,993
-
Price per share
-
$18.49
-
Number of holders
-
48
-
Value change
-
+$8,319,713
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of NEURODERM LTD - ORD SHS as of Q3 2016
As of 30 Sep 2016,
NEURODERM LTD - ORD SHS was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,228,073 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, Redmile Group, LLC, venBio Select Advisor LLC, MENORA MIVTACHIM HOLDINGS LTD., ACUTA CAPITAL PARTNERS, LLC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, ADAGE CAPITAL PARTNERS GP, L.L.C., PERCEPTIVE ADVISORS LLC, and Arrowpoint Asset Management, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.